These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35701718)
1. Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer's Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation. Zhou C; Jung CG; Kim MJ; Watanabe A; Abdelhamid M; Taslima F; Michikawa M Mol Neurobiol; 2022 Sep; 59(9):5408-5425. PubMed ID: 35701718 [TBL] [Abstract][Full Text] [Related]
2. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease. Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J eNeuro; 2017; 4(2):. PubMed ID: 28374012 [TBL] [Abstract][Full Text] [Related]
3. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model. Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145 [TBL] [Abstract][Full Text] [Related]
4. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. Planel E; Tatebayashi Y; Miyasaka T; Liu L; Wang L; Herman M; Yu WH; Luchsinger JA; Wadzinski B; Duff KE; Takashima A J Neurosci; 2007 Dec; 27(50):13635-48. PubMed ID: 18077675 [TBL] [Abstract][Full Text] [Related]
5. Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice. Canet G; Gratuze M; Zussy C; Bouali ML; Diaz SD; Rocaboy E; Laliberté F; El Khoury NB; Tremblay C; Morin F; Calon F; Hébert SS; Julien C; Planel E Neurobiol Dis; 2024 Aug; 198():106526. PubMed ID: 38734152 [TBL] [Abstract][Full Text] [Related]
6. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models. Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638 [TBL] [Abstract][Full Text] [Related]
7. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814 [TBL] [Abstract][Full Text] [Related]
8. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
9. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414 [TBL] [Abstract][Full Text] [Related]
10. RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model. Wang Y; Yang JQ; Hong TT; Sun YH; Huang HL; Chen F; Chen XJ; Chen HY; Dong SS; Cui LL; Yang TL Aging Cell; 2020 Aug; 19(8):e13194. PubMed ID: 32700357 [TBL] [Abstract][Full Text] [Related]
11. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease. Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells. Chen Y; Zhou C; Abdelhamid M; Jung CG; Michikawa M J Biochem; 2023 Oct; 174(5):409-420. PubMed ID: 37488092 [TBL] [Abstract][Full Text] [Related]
13. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
14. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease. Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772 [TBL] [Abstract][Full Text] [Related]
15. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710 [TBL] [Abstract][Full Text] [Related]
17. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model. Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036 [TBL] [Abstract][Full Text] [Related]
18. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease. Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254 [TBL] [Abstract][Full Text] [Related]
19. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease. Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103 [TBL] [Abstract][Full Text] [Related]
20. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]